Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ascendis Pharma AS stock

Learn how to easily invest in Ascendis Pharma AS stock.

Ascendis Pharma AS is a biotechnology business based in the US. Ascendis Pharma AS shares (ASND) are listed on the NASDAQ and all prices are listed in US Dollars. Ascendis Pharma AS employs 639 staff and has a trailing 12-month revenue of around $33.2 million.

How to buy Ascendis Pharma AS stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ASND. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Ascendis Pharma AS stock price (NASDAQ: ASND)

Use our graph to track the performance of ASND stocks over time.

Ascendis Pharma AS shares at a glance

Information last updated 2023-02-02.
Latest market close$117.74
52-week range$61.58 - $134.53
50-day moving average $119.87
200-day moving average $103.08
Wall St. target price$0.39
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-8.46

Buy Ascendis Pharma AS stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Ascendis Pharma AS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ascendis Pharma AS price performance over time

Historical closes compared with the close of $117.74 from 2023-02-02

1 week (2023-01-27) -3.89%
1 month (2023-01-03) -2.47%
3 months (2022-11-03) -1.70%
6 months (2022-08-03) 32.34%
1 year (2022-02-03) 1.64%
2 years (2021-02-03) -21.50%
3 years (2020-02-03) 140.05
5 years (2018-02-02) 136.47%

Ascendis Pharma AS financials

Revenue TTM $33.2 million
Gross profit TTM $4.3 million
Return on assets TTM -26.58%
Return on equity TTM -66.69%
Profit margin 0%
Book value $8.08
Market capitalisation $6.8 billion

TTM: trailing 12 months

Ascendis Pharma AS share dividends

We're not expecting Ascendis Pharma AS to pay a dividend over the next 12 months.

Ascendis Pharma AS share price volatility

Over the last 12 months, Ascendis Pharma AS's shares have ranged in value from as little as $61.579 up to $134.525. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ascendis Pharma AS's is 0.4754. This would suggest that Ascendis Pharma AS's shares are less volatile than average (for this exchange).

Ascendis Pharma AS overview

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. .

Frequently asked questions

What percentage of Ascendis Pharma AS is owned by insiders or institutions?
Currently 0.059% of Ascendis Pharma AS shares are held by insiders and 120.027% by institutions.
How many people work for Ascendis Pharma AS?
Latest data suggests 639 work at Ascendis Pharma AS.
When does the fiscal year end for Ascendis Pharma AS?
Ascendis Pharma AS's fiscal year ends in December.
Where is Ascendis Pharma AS based?
Ascendis Pharma AS's address is: Tuborg Boulevard 12, Hellerup, Denmark, 2900
What is Ascendis Pharma AS's ISIN number?
Ascendis Pharma AS's international securities identification number is: US04351P1012
What is Ascendis Pharma AS's CUSIP number?
Ascendis Pharma AS's Committee on Uniform Securities Identification Procedures number is: 04351P101

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site